前收市價 | 124.02 |
開市 | 122.92 |
買盤 | 122.90 x 1200 |
賣出價 | 123.13 x 800 |
今日波幅 | 121.29 - 123.77 |
52 週波幅 | 75.56 - 138.28 |
成交量 | |
平均成交量 | 4,903,335 |
市值 | 548.932B |
Beta 值 (5 年,每月) | 0.19 |
市盈率 (最近 12 個月) | 46.09 |
每股盈利 (最近 12 個月) | 2.67 |
業績公佈日 | 2024年5月03日 |
遠期股息及收益率 | 1.37 (1.06%) |
除息日 | 2024年3月22日 |
1 年預測目標價 | 145.78 |
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript May 2, 2024 Novo Nordisk A/S misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.77. NVO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day! And thank […]
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.